- Home
- VIPS vs BBIO Comparison
VIPS vs BBIO Comparison
Compare VIPS & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIPS
- BBIO
- Stock Information
- Founded
- VIPS 2008
- BBIO 2015
- Country
- VIPS China
- BBIO United States
- Employees
- VIPS N/A
- BBIO N/A
- Industry
- VIPS Catalog/Specialty Distribution
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- VIPS Consumer Discretionary
- BBIO Health Care
- Exchange
- VIPS Nasdaq
- BBIO Nasdaq
- Market Cap
- VIPS 8.0B
- BBIO 6.7B
- IPO Year
- VIPS 2012
- BBIO 2019
- Fundamental
- Price
- VIPS $13.79
- BBIO $34.25
- Analyst Decision
- VIPS Hold
- BBIO Strong Buy
- Analyst Count
- VIPS 5
- BBIO 12
- Target Price
- VIPS $15.75
- BBIO $57.09
- AVG Volume (30 Days)
- VIPS 4.2M
- BBIO 2.9M
- Earning Date
- VIPS 05-20-2025
- BBIO 04-29-2025
- Dividend Yield
- VIPS 3.48%
- BBIO N/A
- EPS Growth
- VIPS N/A
- BBIO N/A
- EPS
- VIPS 1.91
- BBIO N/A
- Revenue
- VIPS $14,751,394,480.00
- BBIO $127,415,000.00
- Revenue This Year
- VIPS $1.56
- BBIO $89.10
- Revenue Next Year
- VIPS $1.81
- BBIO $57.07
- P/E Ratio
- VIPS $7.21
- BBIO N/A
- Revenue Growth
- VIPS N/A
- BBIO N/A
- 52 Week Low
- VIPS $11.50
- BBIO $21.62
- 52 Week High
- VIPS $17.94
- BBIO $39.54
- Technical
- Relative Strength Index (RSI)
- VIPS 43.61
- BBIO 50.58
- Support Level
- VIPS $13.85
- BBIO $31.77
- Resistance Level
- VIPS $14.44
- BBIO $33.93
- Average True Range (ATR)
- VIPS 0.47
- BBIO 1.28
- MACD
- VIPS -0.09
- BBIO -0.09
- Stochastic Oscillator
- VIPS 18.24
- BBIO 57.14
About VIPS Vipshop Holdings Limited
Vipshop is a leading Chinese online discount retailer offering branded products at attractive discounts ranging from 10%-90% off their original price through daily flash sales. It operates warehousing, retailing, product procurements, software development, and information technology support in-house while outsourcing to third-party logistics providers for distribution and shipments. Branded products on Vipshop's platform are sourced mostly through a consignment model with over 29,000 global partners as of Dec. 31, 2023. As of March 31, 2024, Eric Ya Shen, chairman and CEO, has 63.1% voting rights and a 30.9% stake while Arthur Xiaobo Hong, vice chairman and COO, has a 17.6% stake. Leading Chinese social media firm and strategic shareholder Tencent also holds an 11.8% interest.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.